Aziyo Biologics Inc - Ordinary Shares - Class A

NASDAQ:AZYO

12.27

+1.40 (+12.88%)

Market Cap (Intraday)	125.49M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$12.4 Million
Adjusted EPS	-$0.52

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Aziyo Biologics Inc - Ordinary Shares - Class A Stock, NASDAQ:AZYO

12510 Prosperity Drive, Suite 370, Silver Spring, Maryland 20904

United States of America

Phone: +1.240.247.1147

Number of Employees: 163

http://www.aziyo.com

Description

Aziyo Biologics, Inc. operates as a biotechnology company which focuses on regenerative medicine in areas such as cardiology, orthopedics and other medical specialties. It offers cardiac device envelope, vascular surgery, cardiothoracic repair, orthopedics and spine, sports medicine, dermal, and wound care. The company was founded on August 6, 2015 and is headquartered in Silver Spring, MD.